Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy.
| Autor: | Hsu, Shu-Jung1,2 (AUTHOR), Chao, Yen-Cheng1,3 (AUTHOR), Lin, Xia-Hui4 (AUTHOR), Liu, Hua-Hua1 (AUTHOR), Zhang, Yang2 (AUTHOR), Hong, Wei-Feng2 (AUTHOR), Chen, Mao-Pei1 (AUTHOR), Xu, Xin1 (AUTHOR), Zhang, Lan1 (AUTHOR), Ren, Zheng-Gang1 (AUTHOR), Du, Shi-Suo2 (AUTHOR) du.shisuo@zs-hospital.sh.cn, Chen, Rong-Xin1 (AUTHOR) chen.rongxin@zs-hospital.sh.cn |
|---|---|
| Zdroj: | Clinical & Experimental Immunology. Jun2023, Vol. 212 Issue 3, p239-248. 10p. 4 Charts, 6 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|